跳至主要内容
临床试验/NCT04905394
NCT04905394已完成不适用

Short Term Clinical and Radiological Outcomes of Subchondroplasty in the Treatment of Bone Marrow Edema of the Knee

University of Milan2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Pain reduction

研究概览

简要总结

Bone marrow lesions (BMLs) of the knee are common subchondral defects, often associated with pain and functional limitation. Subchondroplasty is a percutaneous procedure in which calcium phosphate is injected inside BML areas, ensuring stability and promoting the deposition of new bone. Primary outcome of this study was to obtain a reduction of the Numeric Rating Scale score of 4 points or more at 6 months follow-up in more than 75% of patients. The secondary outcome was to evaluate the osteoarthritic and bone marrow structure evolution in the months after the procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Atraumatic knee pain for at least 3 months;
  • Failure of conservative treatment (including NSAIDs, physical therapy, intra- articular injection with steroids or hyaluronic acid and bisphosphonates);
  • Mild to moderate osteoarthritis (Kellgren-Lawrence18 grade ≤ 3)
  • BML on a loading area at MRI imaging (femoral condyles and/or tibial plateau)

排除标准

  • Knee pain and functional limitation related to other causes like osteonecrosis
  • Fractures or inflammatory arthritis
  • Ligamentous instabilities
  • Malalignment on the coronal axis greater than 10 degrees in varus/valgus
  • Severe tri-compartmental arthritis (Kellgren-Lawrence grade 4)

结局指标

主要结局

Pain reduction

时间窗: 6 months

Pain reduction of 4 points in numeric rating score

次要结局

  • Radiological evaluation(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pietro Randelli, MD

Professor

University of Milan

研究点 (2)

Loading locations...

相似试验

Clinical and Radiological Outcomes of... | 临床试验